ArticleFrontiers in public health2026
Evolution and synergy of healthcare security policies for rare diseases in China: a quantitative content analysis.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A quantitative content analysis of Chinese policies on fertility-friendly hospital development: a three-dimensional framework.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Managing rare diseases presents substantial challenges to achieving universal health coverage. Despite growing policy interest, limited research has explored the evolution and synergy of healthcare security policies targeting rare diseases. This study addresses this gap through a case study of China. Methods: An innovative analytical framework was developed, structured around three dimensions of policy synergy: horizontal, vertical, and temporal. A comprehensive dataset of national and provincial policy documents related to healthcare security for rare diseases was systematically collected. Analytical techniques included quantitative content analysis, word frequency analysis, and semantic network analysis. Results: A total of 314 policies enacted between 2001 and 2025 remained effective at the time of data collection, showing a general upward trend in both quantity and policy strength. However, the majority of policies were notices and announcements, which typically carry lower enforcement authority than ordinances and regulations. While a diverse array of policy instruments was employed, horizontal synergy across sectors remained limited. Vertically, national policies emphasized screening and support for children with rare diseases, whereas provincial policies focused more on outpatient service subsidies. Conclusion: Rare diseases have gained increasing attention within China's healthcare security policy landscape. Nonetheless, significant gaps in horizontal and vertical policy synergy persist. A systems-based approach is recommended to enhance policy integration and effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.